Darwin Global Management, Ltd.

Q1 2023 13F-HR Holdings

Location
St. Helier, Y9
Holdings as of
3/31/2023
Date filed
5/15/2023
Form type
13F-HR
Num holdings
4
Total value ($000)
$365,623
Net value change ($000)
+204,998 (127.6%)
New positions
1
Sold out positions
1
Turnover %
45.7%
Sector allocation + QoQ delta (equities-only)
Prev filing: 2/14/2023 Next filing: 8/14/2023 SEC filing

Snapshot: Change Analysis

Compared to Q4 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
TGTX 157,187 NEW
Ambrx Biopharma Cayman, Inc. 83,620 485.7%
Top Reduces (Value $000, Stocks/ETFs)
KROS -19,238 -93.5%
Prometheus Biosciences, Inc. -10,052 -100.0%
ARGX -6,519 -5.8%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type